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Abstract
The human tumor H. Ep. #3 maintained in rats could be transferred for 1-8 generations in
treated guinea pigs. H. Ep. #3 grew in the subcutaneous and intramuscular sites in each host at
the same time. The treatment with the combination of X-ray 250 r. and 80 mg/kg of cortisone
turned out to be the optimal conditioning studied. The number of tumor takes averaged 95.7-
100 per cent in the subcutaneous site in guinea pigs treated with optimal conditioning, but in the
intramuscular site, the number of tumor takes was 65.2-93.8 per cent. Host mortality varied from
4.2-37.5 per cent in the hosts treated with optimal conditioning. The subcutaneous tumor weights
in hosts treated with optimal conditioning averaged 3.3 gm, and their intramuscular tumor weights
averaged 5.6-6.2 gm. Tumor weights in hosts treated with only cortisone averaged 1-2 gm in both
subcutaneous and intramuscular sites. Histological findings. for the original tumors were found
to be the same as that for the successful transplanted tumors in the guinea pigs. The malignancy
of the tumor was evaluated by the criteria of anaplasia, invasion, rapidity of growth, and ease of
maintenance of transplants. There was no metastasis found in any organs.
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Many reports on successful heterologous transplantation of tumors have
appeared in recent years. This success was achieved by depositing tumor cells
in certain protected sites, by using embryos, or by using cortisone and irradia-
tion to circumvent immunological response in tne host.
In 1938, and in subsequent years, various types of human and animal
tumors were successfully transplanted to the anterior chamber of the eye of the
guinea pig and other animals by GREENE and his associates8-11. Successful growth
of human tumors in the guinea pig's eye was also reported by SCHILLING et
al.2l, KREMENTZ et aLl" NEWTON20, EICHWALD6, TOWBINSll, DYER and KELLy6.
The brain of mice, rabbits and guinea pigs was used for heterologous
transplantation of tumors by SHIRAI in 192922. Human cancers were successfully
transferred to the brain of guinea pigs and other animals by GREENEl2.1S•
In 1950, the membranous cheek pouch of the hamster was introduced as a
site for heterotransplantation of tumors by LUTZ and associatesl6.l6, and human
cancers were transferred to the cheek pouch and succssfully grown by TOOLAN
26.27
MURPHyl7.l8 reported in 1912 that mammalian tumors can grow in em-
bryonated eggs, although with some variation in success, especially when using
human tumors. In 1955, DAGG, KARNOFSKYet al.2.3.4 successfully transferred
human tumors in the chorioallantoic membrane of chick embryos and yolk sacs
by serial passage.
In 1914 MURPHyl9 showed that mammalian tumors survived longer in rats
repeatedly irradiated than in non-irradiated rats. In !"ecent years TOOLAN24.26
showed that a number of human tumors can be grown successfully on subcu-
taneous implantation in irradiated rats and hamsters. The animals were given
a total dose of 200-300 r. and were implanted with tumors 1-5 days after the
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last radiation treatment, and then serial transfer was successfully done. Further-
more, in 1953 TOOLAN26-33 reported successful transplantation of human cancers
to the subcutaneous tissue of weanling rats or hamsters treated with radiation
and cortisone or with cortisone only. By TOOLAN's reports;S about 90 per cent
of the implanted tumors were growing 12-20 days after implantation following
injection of cortisone. By selection TOOLAN obtained a number of strains of
human tumors which were transferred successively to cortisone-treated hamsters
and rats. The tumors consisted of a human soft part sarcoma of unknown origin,
some human epidermoid carcinomas, and a human embryonal rhabdomyosar-
coma. Some of the transplanted tumors were lethal due to the cachectic state of
the hosts. No growth of human tumors was ever seen in a normal untreated
hamster or rat.
There have been many other reports on successful heterotransplantation of
thesetumors in other conditioned hosts. For instance, GALLILY and WOOLLEy7
and TAKAYAMA and WOOLLEy23 reported successful heterotransplantation of
the human epidermoid carcinoma H. Ep. ~3 in mice treated with X-rays and
cortisone.
The guinea pig as a host for tumor heterotransplantation has been almost
neglected, except for the eye and the brain. The following paper is a descrip-
tion of a successful serial transplantation (f H. Ep. ~ 3 to the subcutaneous and
intramuscular sites in conditioned guinea pigs.
MATERIALS AND METHODS
In this experiment 127 young female guinea pigs about 250 gm. body weight
were used. They were obtained from Rockland Farms, New York. Following
TOOLAN's method, X-ray and cortisone were used for conditioning.
The transplanted tumor was the human epidermoid carcinoma, H. Ep. ~ 3,
which was established and maintained by TOOLAN in 1953 from a metastatic
epidermoid carrlTloma, Grade 3, primary in the buccal mucosa of a human
patient. In our experiment the tumor was usually taken from rats treated with
X-ray and cortisone.
One hundred and three guinea pigs received one single total body dose of 100,
200, 250, or 300 roentgen 1-4 days before implantation of tumor. Two X-ray
machines were used. Each machine was rated at 180 KVP, and 25 m. amp.,
and was equipped with Cu and Al filters of 0.5 mm. and 1.65 mm. thickness re-
spectively. The machines were placed above and below the animals at a distance
of 40 cm. The dose rate was 86 r/min.
Cortisone acetate* was injected subcutaneously into 115 animals including
* Cortisone Acetate (Cortone, Merck) kindly supplied through the courtesy of Merck, Sharp
and Dohme, West Point, Pa.
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103 X-ray irradiated animals at a dose of 40 mg/kg, 60 mg/kg or 80 mg/kg,
soon after implantation of tumor tissues, and then given on every other day for
5-6 times. Other 12 animals are pairfed controls and grafted tumors without
pretreatment.
The human tumor used initially in this experiment was 11-12 day old
tumors of H. Ep. ~ 3 grown in rats treated with X-rays and cortisone. From the
first generation in guinea pigs and thereafter, 11-15 day old tumors grown in
conditioned guinea pigs were used.
The tumor was aseptically extirpated from the hosts, minced with scalpels
and prepared as a suspension in 0.8596 saline solution. To each 100 ml. of this
saline solution was added 10,000 units penicillin and 100 mg. of streptomycin.
One-half ml. of the suspension of tumor tissue oontaining about 400 mg. of tumor
was injected subcutaneously into the right flank and intramuscularly into the
left leg in each host simultaneously. Tumor growth rate was measured as· the
external tumor size and the tumor weight. And animal weight change, percen-
tage of tumor takes, and host mortality were also examined. In addition, a his-
tological examination of the human tumors growing in guinea 'pigs was made.
All instruments and glasswares were sterilized, and the tumor suspension for
transplantation was made and injected aseptically into conditioned guinea pigs.
RESULTS
H. Ep. # 3 tumors which were implanted subcutaneously and intramuscu-
larly in the guinea pigs grew progressively for at least 2 weeks. After a period
of 2 weeks, the tumors became so regressive, and sometimes necrotic, that it
was found advisable to use an 11-15 day old tumor for transplantation into the
next generation. Usually tumors grown in guinea pigs were regressing 3 weeks
after implantation.
In general, there was no remarkable difference in the growth rate measured
as the external tumor size of tumors when these were transplanted subcutane-
ouslyas compared with tumors transplanted intramuscularly. However, there
was a variation in the external tumor size in the X-ray and cortisone-treated
guinea pigs as compared with guinea pigs treated with cortisone only. The
tumors grew larger in the X-ray and cortisone-treated hosts, as shown in Table
1.
The animal body weight varied depending on the tumor growth in the host
especially when treated with different conditioning, as shown in Table 1.
The tumor weight in the host treated with X-ray and cortisone was slightly
greater in the intramuscular site than in the subcutaneous site; and in the host
treated with cortisone only the tumor weight in both sites was small, as shown
in Table 1.
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Table 1. Population Data Derived from H. Ep. #3 Tumor-Bearing,
Conditioned Guinea Pigs for 15 Days
1 Total No. Measurments
Treatment No. of Guinea Pigs
X-ray*l), Cortisone*2) 41
cortisone 12
non-conditioned 12
2 Animal Weight Change (in increase %)
Treatment days after implantation
3 6 9 12 15
X-ray, cortisone 2.3 13.9 13.7 13.1 2.7
cortisone 4.6 7.4 14.2 20.5 21.3
non-conditioned 5.7 9.2 16.7 18.0 21.2
3 Takes of H. Ep. # 3 (per cent)
a) Subcutaneous
Treatment days after implantation
7 14
X-ray, cortisone 95.7 100.0
cortisone 50.0 50.0
non-conditioned 0 0
b) Intramuscular
Treatment days after implantation
7 14
X-ray, cortisone 65.2 93.8
cortisone 16.7 16.7
non-conditioned 0 0
4 Host Mortality (per cent)
Treatment days after implantation
7 14
,-
cortisone 4.2 37.5••-ray,
cortisone 0 0
non-conditioned 0 8.3
5 Tumor Size (external mean diameter mm.)
a) Subcutaneous
Treatment days after implantation
6 9 12 15
X-ray, cortisone 13.9 17.3 21.2 24.5
cortisone 10.4 12.8 12.2 11.9
b) Intramuscular
Treatment days after implatation
6 9 12 15
X-ray, cortisone 16.8 19.9 26.0 27.0
cortisone 10.1 12.5 15.6 13.2
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6 Tumor Weight (gm.)
a) Subcutaneous
Treatment days after implantation
12 15
X-ray, cortisone 3.3 4.7
cortisone 1.1 1.2
b) Intramuscular
Treatment days after implantation
12 15
X-ray, cortisone 5.6 6.2
cortisone 1.8 1.2
*1). X-ray 250 r., *2). 80 mg. /kg. of cortisone
The external tumor size and animal weight change were measured every
two days for 15 days, and the tumor weight in the sacrificed host was measured
on the 12th day and 15th day after implantation.
Tumor takes were high in the host treated with X-ray and cortisone almost
100 per cent. On the other hand, tumor takes were low in the host conditioned
by cortisone only. The number of tumor takes in the latter was 50 per cent on
the 7th day as well as on the 14th day after implantation. In the non-conditioned
host, there were no tumor takes.
The highest mortality for the host treated with 250 r. and 80 mg/kgof
cortisone was 37.5 per cent on the 14th day after implantation. In the host
treated with cortisone only and non-conditioned, the host mortality was 0-8.3
per cent.
The transplantability of H. Ep. #3 in guinea pigs, as summarized in Table
2, shows that when the guinea pigs are treated with 100-300 r. and 40-80
mg/kg of cortisone tumors grow for 3-8 generations. In the guinea pigs treated
with 250 r. and 80 mg/kg of cortisone, the serial heterotransplantation of H.
Table 2. The Transplantability of H. Ep. #3 Tumor in Guinea Pigs
Conditioning Generations Number of
X-ray (r.) Cortisone (mg/kg) Site of Growth Guinea Pigs
300 80 s. c. & i.m. 5 20
250 80 s. c. & i.m. 8 41
0 80 s. c. & i.m. 1 12
200 60 s. c. & i.m. 4 24
100 40 s. c. & i.m. 3 18
0 0 s. c. & i.m. 0 12
The sites of inoculation were subcutaneous =s. c.; and intramuscular = i. m.
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Ep. ~ 3 was successful through eight generations. Therefore, the treatment
with the combination of 250 r. and 80 mg/kg of cortisone should be considered
as the optimal conditioning investigated.
A histological examination was made of the tumors serially grown in guinea
pigs. It was confirmed by means of the histological findings of the tumor grown
in guinea pigs that the tumor was the same as the original tumor grown in rats.
DISCUSSION
It might be of importance in the interpretation of our results to survey the
tumor growth rate in different transplantation sites, histological findings, reg-
ression, the effect" of conditioning and tumor growth on the host, the adequate
treatment of the host, and the malignancy of the tumor.
H. Ep. ~ 3 tumors implanted in subcutaneous and intramuscular sites in
the. treated guinea pigs grew rapidly in two weeks, and could be successfully
transferred to 1-8 generations. Intramuscular tumors showed greater growth
as compared to the subcutaneous tumors. It was conceivable that the reason for
greater growth with intramuscular transplants was due to a rich~r blood supply
in the intramuscular site; this was proved by a histological examination of the
tumor transplant. In the histological findings of 4-:-6 day old tumors profuse
hemorrhage and island-like tumor tissues could be seen among the hemorrhagic
muscle tissues. This was not as prevalent in the early tumors in the subcutaneous
site.
In general, histological examinations of H. Ep. ~ 3 tumor showed the find-
ings of epidermoid carcinoma similar to that in the original and transplanted
tumors. In the hist')logical findings of the serially transplanted tumors many
mitosis usually appeared, but when the tumor underwent regression, mitosis
were reduced.
It was noted that the regression of the tumor grown in the treated host
occurred in the third week after implantation when no further injections of
cortisone were given. Therefore, long-continued injections of cortisone were
not given in this experiment.
The hosts showed various mortalities according to the different treatments.
Moreover, the host mortality was extensively affected by various conditions;
for example, the guinea pig's disease, if prf'sent, and other sometimes unknown
factors. The mortality of the hosts treated with the conditioning, believed opti-
mal, 250 r. and 80 mg/kg of cortisone was 4.2 per cent on the 7th day and 37.5
per cent on the 14th day after implantation.
Our results showed that tumor takes rate was almost 100 per cent in the
hosts treated with optimal conditioning, aud tumors grown in these hosts were
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serially transferred for 8 generation. In the hosts without treatment, there were
no tumor takes. Consequently, the necessity of the treatment with the combina-
tion of X-ray and cortisone was evident for heterotransplantation of H. Ep. #3
tumors into guinea pigs.
It is not yet fully understood how to inhibit the immunological response of
the hosts to heterologous transplants by various types arid regimes of condition-
ing. The main effect of cortisone is ascribable to its generally accepted ability
to reduce antibody formation. It has been confirmed that prior irradiation of the
hosts} partially breaks down resistance to heterologous transplants.
Among the various cricteria34 ,36 used to evaluate the malignancy of tumors
grown in conditioned hosts, these following criteria - - anaplasia, rapidity of
growth and ease of maintenance of transplants t. were useful for evaluating the
tumor grown in the conditioned guinea pigs, and although evident, no metastasis
could be found in the host.
SUMMARY
The human tumor H. Ep. #3 maintained in rats could' be transferred for 1
-8 generations in treated guinea pigs. H. Ep. #3 grew in the subcutaneous
and intramuscular sites in each host at the same time.
The treatment with the combination of X-ray 250 r. and 80 mg/kg <ilf
cortisone turned out to be the optimal conditioning studied.
The number of tumor takes averaged ~5.7-100per cent in the subcutaneous
site in g~inea pigs treated with optimal conditioning, but in the intramuscular
site, the number of tumor takes was 65.2-93.8 per cent. Host mortality varied
from 4.2-37.5 per cent in the hosts treated with optimal conditioning.
The subcutaneous tumor weights in hosts treated with optimal conditioning
averaged 3.3 gm, and their intramuscular tumor weights averaged 5.6-6.2 gm.
Tumor weights in hosts treated with only cortisone averaged 1-2 gm in both
subcutaneous and intramuscular sites.
Histological findings. for the original tumors were found to be the same as
that for the successful transplanted tumors in the guinea pigs.
The malignancy of the tumor was evaluated by the criteria of anaplasia,
invasion, rapidity of growth, and ease of maintenance of transplants. There
was no metastasis found in any organs. .,
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Fig. 1. H, Fp. :::: 3, 5th gCI1::Lltiul1, 9 chy;; aft::r ~;uh:'utan::;):ls ane! intram us-
cular implantation into guinea pig treatcd with \.-ray ane! cortisone.
Fig. 2. H. Ep. # 3, 11 cla~' old tllmor grown in treated rat and implanted into
gl1ine;\ pig (original 111mor),
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Fig. 3. H. Ep. ::: 3, 7th generation, 9 day~ after intramu~cular implantation into treated
guinea pig. Mitotic figure~ are prominent and general morphology is similar to the original
tumor.
Fig. 4. H. Ep. ::: 3, 7th generation, 9 days after suhcutaneous implant;ltion into treated
guinea pig. The tUll10r has invaded the suhcutis.
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